We are live on ! Find out more
CA

CHI Advisors Portfolio holdings

AUM $252M
1-Year Est. Return 56.99%
This Fund
S&P 500
This Quarter Est. Return
+13.19%
1 Year Est. Return
+56.99%
3 Year Est. Return
+88.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$500M
AUM Growth
+$145M
Cap. Flow
+$168M
Cap. Flow %
33.56%
Top 10 Hldgs %
91.39%
Holding
26
New
3
Increased
6
Reduced
11
Closed
5

Top Buys

Rank Stock Value
1
CGEM icon
Cullinan Oncology
CGEM
+$89.4M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$59.3M
3
IMA
ImageneBio Inc
IMA
+$23.3M
4
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$7.96M
5
ONCR
Oncorus, Inc.
ONCR
+$1.9M

Top Sells

Rank Stock Value
1
AMWL icon
American Well
AMWL
+$6.29M
2
KROS icon
Keros Therapeutics
KROS
+$2.12M
3
OVID icon
Ovid Therapeutics
OVID
+$1.93M
4
DTIL icon
Precision BioSciences
DTIL
+$1.88M
5
INZY
Inozyme Pharma
INZY
+$1.5M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GBT
26
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-20,000
Closed -$8K
1
2

Similar funds

SC
Samjo Capital New York $254M AUM 36.81% 1-Year Est. Return
T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
TOGEPT
Trustees of General Electric Pension Trust Norwalk, Connecticut $245M AUM 128.88% 1-Year Est. Return
IAM
Innovis Asset Management Chicago, Illinois $260M AUM 28.13% 1-Year Est. Return
RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return

CHI Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, CHI Advisors held 26 positions worth $500M, up 41% from $355M the previous quarter. Its ten largest holdings account for 91% of the portfolio.

CHI Advisors deployed $168M of net new capital in Q1 2021, opening 3 new positions and adding to 6 existing holdings. Its largest new stake was Cullinan Oncology: 2,202,407 shares worth $91.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

On the sell side, the largest reduction was Keros Therapeutics, an estimated $2.12M trimmed.

  • CHI Advisors's largest Q1 2021 buy was Cullinan Oncology: 2,202,407 shares worth $91.8M.
  • CHI Advisors added most to Orchard Therapeutics plc American Depositary Shares in Q1 2021, an estimated $7.96M increase.
  • CHI Advisors's biggest Q1 2021 reduction was Keros Therapeutics, cutting an estimated $2.12M.
  • CHI Advisors fully exited American Well in Q1 2021, selling an estimated $6.29M.
  • CHI Advisors's ten largest holdings make up 91% of its $500M portfolio in Q1 2021.
  • CHI Advisors opened 3 new positions and closed 5 in Q1 2021.
  • CHI Advisors's portfolio value rose 41% quarter-over-quarter to $500M.

Based on CHI Advisors's 13F filing for Q1 2021, filed 14 May 2021.